Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial
Authors
Jay L. Koyner (ORCID: https://orcid.org/0000-0001-6873-8712)
Nicolas Noiseux (ORCID: https://orcid.org/0000-0002-0946-8748)
Alexander Zarbock (ORCID: https://orcid.org/0000-0002-2124-1714)
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial
Jay L. Koyner, Nicolas Noiseux, Alexander Zarbock, Matthias Thielmann et al.
Citations
6 citations
Journal
EClinicalMedicine
Topics
Acute Kidney Injury Research
Field-Weighted Citation Impact (FWCI)
2.04
article
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial
Jay L. Koyner, Nicolas Noiseux, Alexander Zarbock, Matthias Thielmann, C. David Mazer, Benoît de Varennes, Klaus Matschke, Andrej Myjavec, Daniel T. Engelman, Maxime Laflamme, Michael Reusch, J Böhm, Tobias E. Larsson, Andreas Böning, Jan Burkert
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 76
Institutions
St. Michael's Hospital (CA), Baystate Medical Center (US), University of Toronto (CA), Justus-Liebig-Universität Gießen (DE), Charles University (CZ), University of Chicago (US), Royal Victoria Hospital (CA), University Hospital in Motol (CZ), University Hospital Münster (DE), Deutsches Herzzentrum der Charité (DE), Institut universitaire de cardiologie et de pneumologie de Québec (CA), University Hospital Hradec Králové (CZ), Centre Hospitalier de l’Université de Montréal (CA), Deutsches Herzzentrum München (DE), West German Heart and Vascular Center Essen (DE), University of Duisburg-Essen (DE), Technical University of Munich (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial — Jay L. Koyner, Nicolas Noiseux, et al. · EClinicalMedicine (2024) | TGRS Research Map | TGRS